• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study.

作者信息

Jiang Jie-Ling, Chen Ming, Wang Li-Ning, Wan Min, Gao Wen-Hui, Wang Ling, Hu Jiong

机构信息

Shanghai Institute of Hematology, Blood & Marrow Transplantation Center, Collaborative Innovation Center of Hematology, Department of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Clinical Research Center (SCRC), Feng Lin International Centre, Shanghai, China.

出版信息

Bone Marrow Transplant. 2022 May;57(5):843-845. doi: 10.1038/s41409-022-01643-4. Epub 2022 Mar 24.

DOI:10.1038/s41409-022-01643-4
PMID:35332301
Abstract
摘要

相似文献

1
Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study.基于双烷化剂的预处理降低了成年髓系恶性肿瘤患者异基因外周血干细胞移植后的复发率：一项单臂II期研究。
Bone Marrow Transplant. 2022 May;57(5):843-845. doi: 10.1038/s41409-022-01643-4. Epub 2022 Mar 24.
2
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.急性白血病减低强度预处理方案后外周血干细胞移植与骨髓移植的比较：欧洲血液与骨髓移植协会急性白血病工作组报告
Haematologica. 2016 Feb;101(2):256-62. doi: 10.3324/haematol.2015.135699. Epub 2015 Nov 12.
3
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.基于苏消安预处理方案治疗急性髓系白血病患者的长期预后：欧洲血液与骨髓移植学会急性白血病工作组的报告
Cancer. 2017 Jul 15;123(14):2671-2679. doi: 10.1002/cncr.30646. Epub 2017 Mar 22.
4
[Efficacy and Relapse Prediction Model of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Acute Leukemia].[异基因外周血干细胞移植治疗成人急性白血病的疗效及复发预测模型]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Jun;29(3):696-702. doi: 10.19746/j.cnki.issn.1009-2137.2021.03.007.
5
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.动员外周血干细胞与骨髓作为干细胞来源用于完全缓解的急性髓系白血病患者的非亲缘供体异基因移植的减低强度预处理：来自欧洲血液和骨髓移植学会急性白血病工作组的分析。
Biol Blood Marrow Transplant. 2012 Sep;18(9):1422-9. doi: 10.1016/j.bbmt.2012.02.013. Epub 2012 Mar 20.
6
[Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].[采用FLAG序贯白消安/环磷酰胺预处理方案进行异基因造血干细胞移植治疗难治/复发急性髓系白血病的临床结局]
Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):576-581. doi: 10.3760/cma.j.issn.0578-1426.2018.08.008.
7
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
8
Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation.
Bone Marrow Transplant. 2022 Jun;57(6):1042-1044. doi: 10.1038/s41409-022-01676-9. Epub 2022 Apr 19.
9
Fludarabine and intravenous busulfan conditioning with post-transplantation cyclophosphamide for allogeneic peripheral stem cell transplantation for adult patients with lymphoid malignancies: a prospective single-arm phase II study.氟达拉滨和静脉用白消安预处理联合移植后环磷酰胺治疗成人淋巴恶性肿瘤患者的异基因外周血干细胞移植：一项前瞻性单臂 II 期研究。
Front Med. 2021 Feb;15(1):108-115. doi: 10.1007/s11684-019-0730-8. Epub 2020 Jun 10.
10
Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 Expression.低 WT1 表达的急性髓系白血病患者中，清髓性（CyTBI、BuCy）与减低强度（FluBu2TBI400）外周血造血干细胞移植的比较。
Biol Blood Marrow Transplant. 2020 Nov;26(11):2018-2026. doi: 10.1016/j.bbmt.2020.07.006. Epub 2020 Jul 11.

引用本文的文献

1
The modified melphalan and busulfan-based regimen combined with maintenance therapy improved the survival of patients with refractory/relapsed AML after allogeneic transplantation: middle-term outcome of a multicenter trial.改良马法兰和白消安方案联合维持治疗可改善异基因移植后难治性/复发性急性髓系白血病患者的生存率：一项多中心试验的中期结果
Am J Cancer Res. 2024 Oct 15;14(10):4969-4978. doi: 10.62347/SKXB3242. eCollection 2024.
2
Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study.氟达拉滨、白消安和马法兰预处理方案用于成年髓系恶性肿瘤患者异基因造血干细胞移植：一项多中心回顾性研究
EJHaem. 2024 Jul 8;5(4):757-767. doi: 10.1002/jha2.947. eCollection 2024 Aug.
3
Case Report: Successful therapy with all- retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the fusion gene.病例报告：全反式维甲酸联合化疗继以造血干细胞移植成功治疗携带融合基因的急性早幼粒细胞白血病。
Front Oncol. 2022 Sep 23;12:1013046. doi: 10.3389/fonc.2022.1013046. eCollection 2022.